1.
Clin Chem
; 70(6): 786-788, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38441566
2.
3.
Yale J Biol Med
; 93(1): 45-47, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32226335
RESUMO
Diltiazem is a calcium-channel blocker commonly used for the treatment of hypertension. Common adverse effects include dizziness, headache, and edema. Fewer than 20 cases of diltiazem-associated photodistributed hyperpigmentation have been reported in the literature. Here, we present the case of a 71-year-old woman with new-onset facial hyperpigmentation 6 months after initiating treatment with diltiazem.